RETRACTED: Sulforaphane protects brains against hypoxic–ischemic injury through induction of Nrf2-dependent phase 2 enzyme
RETRACTED: Sulforaphane protects brains against hypoxic–ischemic injury through induction of Nrf2-dependent phase 2 enzyme is a paper indexed in ScholarIQ from OpenAlex.
How many citations does RETRACTED: Sulforaphane protects brains against hypoxic–ischemic injury through induction of Nrf2-dependent phase 2 enzyme have?
RETRACTED: Sulforaphane protects brains against hypoxic–ischemic injury through induction of Nrf2-dependent phase 2 enzyme has 154 citations in the OpenAlex counts ScholarIQ stores.
When was RETRACTED: Sulforaphane protects brains against hypoxic–ischemic injury through induction of Nrf2-dependent phase 2 enzyme published?
RETRACTED: Sulforaphane protects brains against hypoxic–ischemic injury through induction of Nrf2-dependent phase 2 enzyme has 2010 year in the ScholarIQ index.
What is the open-access status of RETRACTED: Sulforaphane protects brains against hypoxic–ischemic injury through induction of Nrf2-dependent phase 2 enzyme?
RETRACTED: Sulforaphane protects brains against hypoxic–ischemic injury through induction of Nrf2-dependent phase 2 enzyme has closed oa status in the ScholarIQ index.
What is the DOI of RETRACTED: Sulforaphane protects brains against hypoxic–ischemic injury through induction of Nrf2-dependent phase 2 enzyme?
The DOI for RETRACTED: Sulforaphane protects brains against hypoxic–ischemic injury through induction of Nrf2-dependent phase 2 enzyme is on the source record.
What is the PMID of RETRACTED: Sulforaphane protects brains against hypoxic–ischemic injury through induction of Nrf2-dependent phase 2 enzyme?
The PMID for RETRACTED: Sulforaphane protects brains against hypoxic–ischemic injury through induction of Nrf2-dependent phase 2 enzyme is on the source record.
What is the OpenAlex record for RETRACTED: Sulforaphane protects brains against hypoxic–ischemic injury through induction of Nrf2-dependent phase 2 enzyme?
The OpenAlex for RETRACTED: Sulforaphane protects brains against hypoxic–ischemic injury through induction of Nrf2-dependent phase 2 enzyme is on the source record.